Literature DB >> 10435586

Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.

H Kohzaki1, K Ito, G Huang, H J Wee, Y Murakami, Y Ito.   

Abstract

The chimeric gene, AML1/ETO (MTG8), generated in t(8;21) acute myeloid leukemia enhances the expression of Bcl-2. To evaluate whether this enhancement is the primary role of AML1/ETO in leukemogenesis, effects of over-expression of Bcl-2 in the murine myeloid precursor cell line, 32Dcl3, were examined. When 32Dcl3 cells expressing exogenous Bcl-2 were induced to differentiate, the onset of morphological differentiation was delayed. However, even the cells expressing very high levels of exogenous Bcl-2 eventually underwent differentiation without a significant decrease in the synthesis of Bcl-2. On the contrary, 32Dcl3 cells stably expressing AML1/ETO were completely resistant to differentiation and continued to grow in the presence of G-CSF. These results are consistent with the interpretation that stimulation of Bcl-2 expression is not the primary target of AML1/ETO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435586     DOI: 10.1038/sj.onc.1202735

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation.

Authors:  S A Burel; N Harakawa; L Zhou; T Pabst; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.

Authors:  Karina Barseguian; Bart Lutterbach; Scott W Hiebert; Jeffrey Nickerson; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

Review 3.  A role for RUNX1 in hematopoiesis and myeloid leukemia.

Authors:  Motoshi Ichikawa; Akihide Yoshimi; Masahiro Nakagawa; Nahoko Nishimoto; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

4.  The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

Authors:  Luke F Peterson; Ming Yan; Dong-Er Zhang
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

5.  A distinct epigenetic signature at targets of a leukemia protein.

Authors:  Stefano Rossetti; André T Hoogeveen; Ping Liang; Cornel Stanciu; Peter van der Spek; Nicoletta Sacchi
Journal:  BMC Genomics       Date:  2007-02-01       Impact factor: 3.969

6.  BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.

Authors:  S C Kogan; D E Brown; D B Shultz; B T Truong; V Lallemand-Breitenbach; M C Guillemin; E Lagasse; I L Weissman; J M Bishop
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

Review 7.  A proposal for clinical genetics (genetics in medicine) education for medical technologists and other health professionals in Japan.

Authors:  Hidetsugu Kohzaki
Journal:  Front Public Health       Date:  2014-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.